S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Better Than Oil Stocks (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
Laser breakthrough could send stock soaring 2,467% (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds an annual oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Better Than Oil Stocks (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
Laser breakthrough could send stock soaring 2,467% (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds an annual oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Better Than Oil Stocks (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
Laser breakthrough could send stock soaring 2,467% (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds an annual oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Better Than Oil Stocks (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
Laser breakthrough could send stock soaring 2,467% (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds an annual oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
NASDAQ:OABI

OmniAb (OABI) Stock Forecast, Price & News

$5.19
-0.09 (-1.70%)
(As of 09/29/2023 08:53 PM ET)
Compare
Today's Range
$5.11
$5.34
50-Day Range
$4.98
$5.93
52-Week Range
$1.91
$10.50
Volume
925,100 shs
Average Volume
599,446 shs
Market Capitalization
$602.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00

OmniAb MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
92.7% Upside
$10.00 Price Target
Short Interest
Bearish
4.90% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.54mentions of OmniAb in the last 14 days
Based on 6 Articles This Week
Insider Trading
Acquiring Shares
$246,600 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.45) to ($0.44) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.09 out of 5 stars

Medical Sector

533rd out of 970 stocks

Commercial Physical Research Industry

9th out of 14 stocks


OABI stock logo

About OmniAb (NASDAQ:OABI) Stock

OmniAb, Inc., a biotechnology company, engages in the provision of therapeutic antibody discovery technologies in the United States. The company's discovery platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address industry needs for bispecific antibody applications though a common light chain approach, and OmniTau, which features unique structural attributes of cow antibodies for complex targets. The company was founded in 2012 and is headquartered in Emeryville, California.

OABI Price History

OABI Stock News Headlines

Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
OmniAb: Hold For Growth
OABIW OmniAb, Inc. WT EXP 110127
OmniAb President Acquires 2.0% More Stock
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Truist Financial Remains a Buy on OmniAb (OABI)
OmniAb Announces the Passing of Director Sunil Patel
OmniAb: Plenty Of Potential
OmniAb (OABI) Investor Presentation - Slideshow
OmniAb: 6 Months In And Going Strong
SVB Securities Remains a Buy on OmniAb (OABI)
See More Headlines
Receive OABI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OmniAb and its competitors with MarketBeat's FREE daily newsletter.

OABI Company Calendar

Last Earnings
8/10/2023
Today
10/01/2023
Next Earnings (Estimated)
11/21/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Commercial physical research
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:OABI
Fax
N/A
Employees
95
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$10.00
High Stock Price Forecast
$13.00
Low Stock Price Forecast
$6.00
Forecasted Upside/Downside
+92.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
9 Analysts

Profitability

Net Income
$-22,330,000.00
Pretax Margin
-51.62%

Debt

Sales & Book Value

Annual Sales
$66.12 million
Book Value
$2.96 per share

Miscellaneous

Free Float
108,036,000
Market Cap
$602.91 million
Optionable
Not Optionable
Beta
-0.55
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Matthew W. Foehr (Age 50)
    Pres, CEO & Director
    Comp: $967.72k
  • Mr. Kurt A. Gustafson (Age 55)
    Exec. VP of Fin. & CFO
    Comp: $558.48k
  • Mr. Charles S. Berkman J.D. (Age 54)
    Chief Legal Officer & Sec.
    Comp: $734.33k
  • Ms. Cia McCaffrey
    VP of People & Talent
  • Dr. Bill Harriman Ph.D.
    Sr. VP of Antibody Discovery
  • Ms. Marie-Cecile van de Lavoir D.V.M.
    Ph.D., Sr. VP of Technical Operations & Genetics
  • Dr. Christel Iffland Ph.D.
    Sr. VP of Antibody Technologies
  • Dr. Douglas S. Krafte Ph.D. (Age 65)
    Sr. VP of Ion Channels/Transporters & Icagen Ion Channel Technology Site Head
  • Ms. Donna Ventura CPA
    Sr. VP of Corp. Controller













OABI Stock - Frequently Asked Questions

Should I buy or sell OmniAb stock right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for OmniAb in the last year. There are currently 9 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" OABI shares.
View OABI analyst ratings
or view top-rated stocks.

What is OmniAb's stock price forecast for 2023?

9 Wall Street analysts have issued twelve-month target prices for OmniAb's shares. Their OABI share price forecasts range from $6.00 to $13.00. On average, they anticipate the company's share price to reach $10.00 in the next twelve months. This suggests a possible upside of 92.7% from the stock's current price.
View analysts price targets for OABI
or view top-rated stocks among Wall Street analysts.

How have OABI shares performed in 2023?

OmniAb's stock was trading at $3.60 at the beginning of the year. Since then, OABI stock has increased by 44.2% and is now trading at $5.19.
View the best growth stocks for 2023 here
.

When is OmniAb's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 21st 2023.
View our OABI earnings forecast
.

How were OmniAb's earnings last quarter?

OmniAb, Inc. (NASDAQ:OABI) announced its quarterly earnings results on Thursday, August, 10th. The company reported ($0.15) EPS for the quarter, missing analysts' consensus estimates of ($0.11) by $0.04. The business earned $6.95 million during the quarter, compared to analyst estimates of $13.05 million.

What is OmniAb's stock symbol?

OmniAb trades on the NASDAQ under the ticker symbol "OABI."

How do I buy shares of OmniAb?

Shares of OABI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is OmniAb's stock price today?

One share of OABI stock can currently be purchased for approximately $5.19.

How much money does OmniAb make?

OmniAb (NASDAQ:OABI) has a market capitalization of $602.91 million and generates $66.12 million in revenue each year. The company earns $-22,330,000.00 in net income (profit) each year or ($0.23) on an earnings per share basis.

How can I contact OmniAb?

OmniAb's mailing address is 65 EAST 55TH STREET 18TH FLOOR, NEW YORK NY, 10022. The official website for the company is www.omniab.com. The company can be reached via phone at 510-250-7800 or via email at investors@omniab.com.

This page (NASDAQ:OABI) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -